| Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors A Ruiz-Calvo, IB Maroto, R Bajo-Grañeras, A Chiarlone, Á Gaudioso, ... Cerebral Cortex 28 (1), 307-322, 2018 | 32 | 2018 |
| Lipidomic alterations in the mitochondria of aged parkin null mice relevant to autophagy A Gaudioso, P Garcia-Rozas, MJ Casarejos, O Pastor, ... Frontiers in Neuroscience 13, 329, 2019 | 26 | 2019 |
| Models to study basic and applied aspects of lysosomal storage disorders Á Gaudioso, TP Silva, MD Ledesma Advanced Drug Delivery Reviews 190, 114532, 2022 | 7 | 2022 |
| Peptidoglycan recognition by wheat germ agglutinin. a view by NMR K Biari, Á Gaudioso, MC Fernández-Alonso, J Jiménez-Barbero, ... Natural Product Communications 14 (5), 1934578X19849240, 2019 | 7 | 2019 |
| Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency A Gaudioso, X Jiang, J Casas, EH Schuchman, MD Ledesma Cell Death & Disease 14 (4), 248, 2023 | 4 | 2023 |
| Neurons regulate the esterification of bioactive lipid mediators in the brain of acid sphingomyelinase deficient mice AY Taha, Á Gaudioso, M Moran-Garrido, SM Camunas-Alberca, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 129, 110896, 2024 | | 2024 |
| Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency Á Gaudioso, P Moreno-Huguet, J Casas, EH Schuchman, MD Ledesma International journal of molecular sciences 24 (11), 9756, 2023 | | 2023 |
| Sphingomyelin 16: 0 is a therapeutic target for brain pathology in acid sphingomyelinase deficiency MD Ledesma, A Gaudioso, X Jiang, EH Schuchman Molecular Genetics and Metabolism 138 (2), 107197, 2023 | | 2023 |
| Glial cell-dysfunction and therapeutic potential of trehalose in early Huntingtons disease cellular model A Gaudioso, J Perucho, E Edo, MP Muñoz, A Gómez, Z Hozova, ... GLIA 63, E165-E165, 2015 | | 2015 |
